home / stock / qnrx / qnrx quote
Last: | $0.6375 |
---|---|
Change Percent: | 0.0% |
Open: | $0.63 |
Close: | $0.6375 |
High: | $0.65 |
Low: | $0.6029 |
Volume: | 54,803 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.6375 | $0.63 | $0.6375 | $0.65 | $0.6029 | 54,803 | 04-26-2024 |
$0.63 | $0.668 | $0.63 | $0.6897 | $0.6036 | 242,254 | 04-25-2024 |
$0.6321 | $0.65 | $0.6321 | $0.67 | $0.63 | 54,890 | 04-24-2024 |
$0.66 | $0.66 | $0.66 | $0.675 | $0.65 | 82,259 | 04-23-2024 |
$0.66 | $0.7099 | $0.66 | $0.7399 | $0.63 | 133,652 | 04-22-2024 |
$0.7099 | $0.74 | $0.7099 | $0.74 | $0.6901 | 41,169 | 04-19-2024 |
$0.72 | $0.732 | $0.72 | $0.7325 | $0.71 | 10,044 | 04-18-2024 |
$0.7331 | $0.7324 | $0.7331 | $0.7466 | $0.7002 | 37,109 | 04-17-2024 |
$0.72 | $0.767 | $0.72 | $0.767 | $0.71 | 34,779 | 04-16-2024 |
$0.7139 | $0.75 | $0.7139 | $0.7875 | $0.7055 | 81,537 | 04-15-2024 |
$0.741 | $0.78 | $0.741 | $0.795 | $0.74 | 90,909 | 04-12-2024 |
$0.77 | $0.79 | $0.77 | $0.7979 | $0.7531 | 80,556 | 04-11-2024 |
$0.7832 | $0.8082 | $0.7832 | $0.8082 | $0.7818 | 27,221 | 04-10-2024 |
$0.7919 | $0.78 | $0.7919 | $0.8 | $0.78 | 38,979 | 04-09-2024 |
$0.7801 | $0.84 | $0.7801 | $0.84 | $0.77 | 85,699 | 04-08-2024 |
$0.8101 | $0.88 | $0.8101 | $0.88 | $0.801 | 158,949 | 04-05-2024 |
$0.86 | $0.9 | $0.86 | $0.91 | $0.86 | 58,310 | 04-04-2024 |
$0.89 | $0.91 | $0.89 | $0.93 | $0.85 | 58,443 | 04-03-2024 |
$0.8849 | $0.96 | $0.8849 | $0.96 | $0.8645 | 71,515 | 04-02-2024 |
$0.94 | $0.96 | $0.94 | $0.9789 | $0.9137 | 67,743 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Quoin Pharmaceuticals Ltd. Company Name:
QNRX Stock Symbol:
NASDAQ Market:
Company reported positive initial clinical data for QRX003 from first six evaluable subjects in ongoing open-label Netherton Syndrome study with positive benefits observed across a number of clinical endpoints Eligibility age for enrollment into both studies has been lowered to fourteen...
SuRo Capital Corp. (SSSS) is expected to report for quarter end 2023-12-31 Enviva Inc. (EVA) is expected to report $-0.76 for Q4 2023 Jushi Holdings Inc. - Class B (Sub Voting) (JUSHF) is expected to report $-0.04 for Q4 2023 U Power Limited (UCAR) is expected to report for quarter en...
ASHBURN, Va., March 07, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX) (the "Company" or "Quoin"), a clinical stage specialty...